Table 3 Development of ocular GVHD.

From: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study

Developed oGVHD

21/34 (61.8%)

Time to diagnosis

 <6 months

8 (38.1%)

 6–12 months

11 (52.4%)

 >12 months

2 (9.5%)

Severity of oGVHD at time of diagnosisa

 1

19 (90.5%)

 2

1 (4.8%)

 3

1 (4.8%)

Maximum severity of oGVHD at any timepointa

 1

14 (66.7%)

 2

5 (23.8%)

 3

2 (9.5%)

Organs involvedb

 Eye only

6 (28.6%)

 Eye and others

15 (71.4%)

  1. aSeverity is based on Ocular NIH Organ Scores calculated according to the NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-host Disease 2014 Diagnosis and Staging Working Group Report.
  2. bOrgans involved refers to the entire follow-up period; not just time of initial diagnosis.
Back to article page